{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:34:39Z","timestamp":1772429679073,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["YQ2020H012"],"award-info":[{"award-number":["YQ2020H012"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01359-3","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:06:14Z","timestamp":1772424374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The sialyltransferase ST3GAL1 mediates MUCL1 sialylation to exacerbate breast cancer progression"],"prefix":"10.1007","volume":"39","author":[{"given":"Can","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1586287","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Yu L, Geng C. Expression characteristics, molecular mechanisms, and clinical significance of DICER1 in breast cancer. Front Genet. 2025;16:1586287. https:\/\/doi.org\/10.3389\/fgene.2025.1586287.","journal-title":"Front Genet"},{"issue":"1","key":"1359_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-17322-5","volume":"15","author":"K-H Song","year":"2025","unstructured":"Song K-H, Jung S-Y, Park J-I, et al. SLAMF1 expression in breast cancer cells delays tumor growth in vivo. Sci Rep. 2025;15(1):31247. https:\/\/doi.org\/10.1038\/s41598-025-17322-5.","journal-title":"Sci Rep"},{"key":"1359_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-025-01664-5","author":"P Song","year":"2025","unstructured":"Song P, Zhang L, Qiu H, et al. The role of RANBP1 in regulating MiRNA expression and apoptosis in breast cancer cells. Genes Genomics. 2025. https:\/\/doi.org\/10.1007\/s13258-025-01664-5.","journal-title":"Genes Genomics"},{"issue":"8","key":"1359_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.120043","volume":"1872","author":"P Li","year":"2025","unstructured":"Li P, Wei L, Li M, Yang H. ESCO2 drives breast cancer proliferation and metastasis through PI3K\/AKT\/mTOR phosphorylation: a potential therapeutic target. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2025;1872(8):120043. https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120043.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"issue":"1","key":"1359_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01315-1","volume":"31","author":"Y Qian","year":"2025","unstructured":"Qian Y, Che Y, Li S, et al. POC1A induces epithelial-mesenchymal transition to promote growth and metastasis through the STAT3 signaling pathway in triple-negative breast cancer. Mol Med. 2025;31(1):280. https:\/\/doi.org\/10.1186\/s10020-025-01315-1.","journal-title":"Mol Med"},{"issue":"1","key":"1359_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03932-6","volume":"25","author":"T Dai","year":"2025","unstructured":"Dai T, Xu Z, Li Y, et al. Promotion of the invasion and metastasis of breast cancer by B7-H3 through CCR5High tumor-associated macrophages. Cancer Cell Int. 2025;25(1):293. https:\/\/doi.org\/10.1186\/s12935-025-03932-6.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1359_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100211","volume":"4","author":"Q Pan","year":"2025","unstructured":"Pan Q, Zhang X-L. Roles of core fucosylation modification in immune system and diseases. Cell Insight. 2025;4(1):100211. https:\/\/doi.org\/10.1016\/j.cellin.2024.100211.","journal-title":"Cell Insight"},{"key":"1359_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122471","volume":"343","author":"X Ma","year":"2024","unstructured":"Ma X, Li M, Wang X, Qi G, Wei L, Zhang D. Sialylation in the gut: from mucosal protection to disease pathogenesis. Carbohydr Polym. 2024;343:122471. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122471.","journal-title":"Carbohydr Polym"},{"issue":"8","key":"1359_CR9","first-page":"2136","volume":"10","author":"C De Vellis","year":"2021","unstructured":"De Vellis C, Pietrobono S, Stecca B. The role of glycosylation in melanoma progression. 2021;10(8):2136.","journal-title":"The role of glycosylation in melanoma progression"},{"issue":"1","key":"1359_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03640-1","volume":"25","author":"Y Jian","year":"2025","unstructured":"Jian Y, Yang K, Li J, et al. Comprehensive analysis of \u03b12,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma. Cancer Cell Int. 2025;25(1):36. https:\/\/doi.org\/10.1186\/s12935-025-03640-1.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"1359_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100821","volume":"23","author":"F Chen","year":"2024","unstructured":"Chen F, Gao K, Li Y, et al. ST3GAL1 promotes malignant phenotypes in intrahepatic cholangiocarcinoma. Mol Cell Proteomics. 2024;23(9):100821. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100821.","journal-title":"Mol Cell Proteomics"},{"key":"1359_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7204415","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Jin Y, Gao S, et al. Prognostic signature and therapeutic value based on membrane lipid biosynthesis-related genes in breast cancer. J Oncol. 2022;2022:7204415. https:\/\/doi.org\/10.1155\/2022\/7204415.","journal-title":"J Oncol"},{"issue":"1","key":"1359_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-05924-0","volume":"7","author":"R Garnham","year":"2024","unstructured":"Garnham R, Geh D, Nelson R, et al. ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. Commun Biol. 2024;7(1):276. https:\/\/doi.org\/10.1038\/s42003-024-05924-0.","journal-title":"Commun Biol"},{"issue":"2","key":"1359_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/bbb\/zbae175","volume":"89","author":"M Deminami","year":"2025","unstructured":"Deminami M, Hashimoto M, Takahashi H, et al. Androgens suppress the sialyltransferases ST3GAL1 and ST3GAL4 and modulate mucin 10 glycosylation in the submandibular gland, related to sex differences in commensal microbiota composition in mice. Biosci Biotechnol Biochem. 2025;89(2):241\u201354. https:\/\/doi.org\/10.1093\/bbb\/zbae175.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"1359_CR15","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0784","volume":"18","author":"H Hao","year":"2023","unstructured":"Hao H, Yang L, Wang B, Sang Y, Liu X. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients. Open Life Sci. 2023;18(1):20220784. https:\/\/doi.org\/10.1515\/biol-2022-0784.","journal-title":"Open Life Sci"},{"key":"1359_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5312","author":"M Abdulla","year":"2022","unstructured":"Abdulla M, Traiki TB, Vaali-Mohammed MA, et al. Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating \u03b2\u2011catenin and increases irinotecan sensitivity in colorectal cancer. Int J Oncol. 2022. https:\/\/doi.org\/10.3892\/ijo.2022.5312.","journal-title":"Int J Oncol"},{"issue":"14","key":"1359_CR17","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.18632\/aging.204887","volume":"15","author":"H Hao","year":"2023","unstructured":"Hao H, Wang B, Yang L, et al. miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. Aging. 2023;15(14):6993\u20137007. https:\/\/doi.org\/10.18632\/aging.204887.","journal-title":"Aging"},{"issue":"1","key":"1359_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-024-01137-z","volume":"38","author":"X Chen","year":"2024","unstructured":"Chen X, Su W, Chen J, Ouyang P, Gong J. ST3GAL4 promotes tumorigenesis in breast cancer by enhancing aerobic glycolysis. Hum Cell. 2024;38(1):1. https:\/\/doi.org\/10.1007\/s13577-024-01137-z.","journal-title":"Hum Cell"},{"key":"1359_CR19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-210107","volume":"144","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Lu T, et al. ST6GALNAC4 promotes diffuse large b-cell lymphoma progression via mediating sialylation of Bmpr-1B at Thr24. Blood. 2024;144:833. https:\/\/doi.org\/10.1182\/blood-2024-210107.","journal-title":"Blood"},{"issue":"16","key":"1359_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400088","volume":"19","author":"R Szabo","year":"2024","unstructured":"Szabo R, Dobie C, Montgomery AP, Steele H, Yu H, Skropeta D. Synthesis of \u03b1-hydroxy-1,2,3-triazole-linked sialyltransferase inhibitors and evaluation of selectivity towards ST3GAL1, ST6GAL1 and ST8SIA2. ChemMedChem. 2024;19(16):e202400088. https:\/\/doi.org\/10.1002\/cmdc.202400088.","journal-title":"ChemMedChem"},{"issue":"11","key":"1359_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1101-0","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Zhao J, Ruan Y, Sun L, Xu C, Jiang H. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-\u03b21-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death Dis. 2018;9(11):1102. https:\/\/doi.org\/10.1038\/s41419-018-1101-0.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1359_CR22","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/ijc.31737","volume":"143","author":"Q Yuan","year":"2018","unstructured":"Yuan Q, Chen X, Han Y, et al. Modification of \u03b12,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1\/Hes1\/MMPs pathway. Int J Cancer. 2018;143(9):2319\u201330. https:\/\/doi.org\/10.1002\/ijc.31737.","journal-title":"Int J Cancer"},{"issue":"3","key":"1359_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11596-025-00041-3","volume":"45","author":"YX Chen","year":"2025","unstructured":"Chen YX, Zhao GN, Gao QL. Aberrant sialylation in ovarian cancer: orchestrating progression, metastasis, and therapeutic hurdles. Current medical science. 2025;45(3):395\u2013404. https:\/\/doi.org\/10.1007\/s11596-025-00041-3.","journal-title":"Current medical science"},{"issue":"1","key":"1359_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/2326-6066.Cir-20-0203","volume":"9","author":"WD Lin","year":"2021","unstructured":"Lin WD, Fan TC, Hung JT, et al. Sialylation of CD55 by ST3GAL1 facilitates immune evasion in cancer. Cancer Immunol Res. 2021;9(1):113\u201322. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0203.","journal-title":"Cancer Immunol Res"},{"issue":"13","key":"1359_CR25","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1182\/bloodadvances.2022007001","volume":"6","author":"N Zhang","year":"2022","unstructured":"Zhang N, Lin S, Cui W, Newman PJ. Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation. Blood Adv. 2022;6(13):3945\u201355. https:\/\/doi.org\/10.1182\/bloodadvances.2022007001.","journal-title":"Blood Adv"},{"issue":"1","key":"1359_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1158\/0008-5472.Can-17-1636","volume":"78","author":"T Maeda","year":"2018","unstructured":"Maeda T, Hiraki M, Jin C, et al. MUC1-C induces PD-L1 and immune evasion in triple-negative breast cancer. Cancer Res. 2018;78(1):205\u201315. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-1636.","journal-title":"Cancer Res"},{"key":"1359_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.552099","volume":"10","author":"S Tao","year":"2020","unstructured":"Tao S, Li H, Ma X, et al. Methylation-mediated silencing of MicroRNA-497 promotes breast cancer progression through up-regulation of mucin1. Front Oncol. 2020;10:552099. https:\/\/doi.org\/10.3389\/fonc.2020.552099.","journal-title":"Front Oncol"},{"key":"1359_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47060406","author":"C Chen","year":"2025","unstructured":"Chen C, Patel A, Demirkhanyan L, Gondi CS. The role of mucins in cancer and cancer progression: a comprehensive review. Curr Issues Mol Biol. 2025. https:\/\/doi.org\/10.3390\/cimb47060406.","journal-title":"Curr Issues Mol Biol"},{"key":"1359_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/polym13010103","author":"J Kim","year":"2021","unstructured":"Kim J, Lee B, Lee J, et al. N-Glycan Modifications with negative charge in a natural polymer mucin from bovine submaxillary glands, and their structural role. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13010103.","journal-title":"Polymers"},{"issue":"17","key":"1359_CR30","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/1873-3468.14169","volume":"595","author":"W Liu","year":"2021","unstructured":"Liu W, Ji Z, Wu B, et al. Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44. FEBS Lett. 2021;595(17):2290\u2013302. https:\/\/doi.org\/10.1002\/1873-3468.14169.","journal-title":"FEBS Lett"},{"key":"1359_CR31","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.244020","author":"A Gong","year":"2020","unstructured":"Gong A, Zhao X, Pan Y, et al. The lncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation. J Cell Sci. 2020. https:\/\/doi.org\/10.1242\/jcs.244020.","journal-title":"J Cell Sci"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01359-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T04:06:15Z","timestamp":1772424375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01359-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01359-3","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental protocols have been reviewed and approved by the Animal Ethical and Welfare Committee of Shenzhen Glorybay Biotech Co., Ltd. (RW-IACUC-25\u20130011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The data used in this study have never been published before.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"49"}}